TITLE

Do ASA and NSAIDs reduce the risk of colorectal cancer?

AUTHOR(S)
Murray, Sally
PUB. DATE
November 2005
SOURCE
CMAJ: Canadian Medical Association Journal;11/8/2005, Vol. 173 Issue 10, p1159
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on a study that examined whether long-term use of aspirin and nonsteroidal anti-inflammatory drugs reduces the risk of recurrent colorectal adenoma or cancer. Subjects analyzed for the study; Method used to calculate rates of colorectal cancer for each group of patients.
ACCESSION #
18708994

 

Related Articles

  • Aspirin Use Cuts Colon Cancer, Risk But May Have Side Effect.  // Mayo Clinic Women's Health Source;Apr2006, Vol. 10 Issue 4, p3 

    Focuses on the risks associated with using aspirin regularly to reduce the incidence of colon cancer according to a research from the Nurses' Health Study published in the August 24, 2005 issue of the "Journal of the American Medical Association." Condition that can be developed by taking high...

  • Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendations.  // Annals of Internal Medicine;3/6/2007, Vol. 146 Issue 5, pI35 

    The article offers information concerning the use of aspirin of non-steroidal anti-inflammatory drugs for the prevention of colorectal cancer. A brief description of colorectal cancer is provided, including the ways of preventing the disease such as the chemoprevention and taking doses of...

  • Analgesics against Alzheimer's, cancer?  // Consumer Reports on Health;May2002, Vol. 14 Issue 5, p9 

    Focuses on research that suggests aspirin and other nonsteroidal anti-inflammatories may help prevent or fight various cancers, and help ward off Alzheimer's disease. Risks of colorectal cancers; Aspirin's possible effectiveness at slowing the progression of prostate cancer; Finding that older...

  • NSAIDs protected against colorectal adenomas.  // Hem/Onc Today;6/25/2008, Vol. 9 Issue 11, p21 

    The article reports that continued use of nonsteroidal antiinflammatory drug (NSAID) after the end of random assignment to aspirin resulted in a stronger protection against colorectal adenomas, according to Maria Grau, a research associate at Dartmouth Medical School. The researchers used data...

  • Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.  // Annals of Internal Medicine;3/6/2007, Vol. 146 Issue 5, p361 

    This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is...

  • Case-Control Study of Use of Nonsteroidal Antiinflammatory Drugs and Glioblastoma Multiforme. Sivak-Sears, Niccole R.; Schwartzbaum, Judith A.; Miike, Rei; Moghadassi, Michelle; Wrensch, Margaret // American Journal of Epidemiology;Jun2004, Vol. 159 Issue 12, p1131 

    Evidence from epidemiologic and experimental studies suggests that use of nonsteroidal antiinflammatory drugs (NSAIDs) reduces risk of colon and breast cancer. The association between use of aspirin and other NSAIDs and risk of adult glioblastoma multiforme (GBM) was evaluated among 236 incident...

  • Use of aspirin to prevent colorectal cancer is unwise.  // Journal of Business (10756124);6/14/2007, Vol. 22 Issue 13, pB8 

    The article reports that the U.S. Preventive Services Task Force recommends that people who are at average risk for colorectal cancer should not take aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) to try to prevent the disease. It was found that the potential harm of taking more than...

  • Task force issues warning on aspirin. Arias, Donya C. // Nation's Health;May2007, Vol. 37 Issue 4, p10 

    The article reports on a recommendation from the U.S. Preventive Services Task Force that people who are at risk for colorectal cancer should not take aspirin and non-steroidal anti-inflammatory drugs to try to prevent the cancer. The task force found that increased risk for stroke, intestinal...

  • The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force. Dubé, Catherine; Rostom, Alaa; Lewin, Gabriela; Tsertsvadze, Alexander; Barrowman, Nicholas; Code, Catherine; Sampson, Margaret; Moher, David // Annals of Internal Medicine;3/6/2007, Vol. 146 Issue 5, p365 

    Background: Aspirin for prevention of colorectal cancer is controversial. Purpose: To examine the benefits and harms of aspirin chemoprevention. Data Sources: MEDLINE, 1966 to December 2006; EMBASE, 1980 to April 2005; CENTRAL, Cochrane Collaboration's registry of clinical trials; Cochrane...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics